A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Ichthyosis Vulgaris Clinical Trial

Official title:
A Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of 146-9251 Cream Applied Twice-daily for Six Weeks in Subjects With Ichthyosis Vulgaris

Status Completed

Clinical Trial Summary

The objective of this study is to determine and compare the safety and efficacy of topical 146-9251 cream and vehicle cream applied twice daily for 6 weeks in subjects with moderate to severe ichthyosis vulgaris (IV).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03173547
Study type	Interventional
Source	Crown Laboratories, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	April 25, 2017
Completion date	July 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT02978209` - Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris	N/A
Recruiting	`NCT04750161` - The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders
Completed	`NCT01016106` - Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population	N/A
Recruiting	`NCT00605878` - Studies of Skin Microbes in Healthy People and in People With Skin Conditions